For the Inventor, By the Inventor

Enter assignee name

Concord, CA, United States of America

Cerus Corporation

USPTO Granted Patents = 72

CIPO Patents = 6

EPO Patents = 14

Trademarks = 14

Forward Citations = 1,470

Loading Chart...

Loading Chart...

59 inventors (with patents filed for the assignee):

Susan Wollowitz (25 out of 36 patents)

Stephen T Isaacs (22 out of 39 patents)

Henry Rapoport (17 out of 48 patents)

4. George D Cimino (16 out of 34 patents)

5. Aileen Nerio (16 out of 18 patents)

6. Hans Peter Spielmann (15 out of 22 patents)

7. David N Cook (10 out of 21 patents)

8. Adonis Stassinopoulos (9 out of 13 patents)

9. Derek J Hei (8 out of 12 patents)

10. Laurence Corash (7 out of 11 patents)

11. Daniel Church (7 out of 7 patents)

12. Naheed Mufti (6 out of 6 patents)

13. John E Hearst (6 out of 22 patents)

14. Anna Erickson (5 out of 5 patents)

15. David Paul Hearst (5 out of 7 patents)

Core Competencies:

Biological Fluid Treatment

Pathogen Inactivation

Platelet Compositions

Cryoprecipitate Compositions

Photoactivation Devices

Red Blood Cell Processing

Synthetic Platelet Storage

Photodecontamination Methods

Car-T Cell Therapies

Porous Particles

Fluid Processing Systems

Quenching Methods

72 patents: Sort by Forward Citations

1. 12343436 - System and methods for implementing a biological fluid treatment device (2025-07-01),

2. 12282015 - Systems and methods for testing and screening using compound bound substrates (2025-04-21),

3. 12214092 - Systems and methods for treating biological fluids (2025-02-04),

4. D1042788 - Illuminator device (2024-09-17),

5. 12064537 - Kits and methods for preparing pathogen-inactivated platelet compositions (2024-08-20),

6. D1035969 - Illuminator device (2024-07-16),

7. 12011510 - Biological fluid treatment systems (2024-06-18),

8. 11883544 - System and methods for implementing a biological fluid treatment device (2024-01-30),

9. 11554185 - Systems and methods for treating biological fluids (2023-01-17),

10. 11235090 - Kits and methods for preparing pathogen-inactivated platelet compositions (2022-02-01),

11. 11096963 - Cryoprecipitate compositions and methods of preparation thereof (2021-08-24),

12. 10842818 - Methods for preparing platelet products (2020-11-24),

13. 10799533 - Plasma compositions and methods of use thereof (2020-10-13),

14. 10688166 - Compositions and methods for improved car-T cell therapies (2020-06-23),

15. 10357516 - Pathogen-inactivated red blood cell compositions (2019-07-23),

Cerus Corporation is a biomedical products company focused on developing and commercializing innovative technologies to enhance the safety of the blood supply. Their Intercept Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites that may be present in donated blood.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

72 Patents

#3 in Concord, CA

#1,160 in California

#4,879 in US

#9,952 in the World

Concord, CA, United States of America

Cerus Corporation

Forward Citations = 1,470

59 inventors:

Susan Wollowitz (25 out of 36 patents)

Stephen T Isaacs (22 out of 39 patents)

Henry Rapoport (17 out of 48 patents)

4. George D Cimino (16 out of 34 patents)

5. Aileen Nerio (16 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…